Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy

International Journal of Oncology

Volumn 35, Issue 2, 2009, Pages 369-374

  Sofiadis, Anastasios ^a,b   Tani, Edneia ^a   Foukakis, Theodoros ^a   Kjellman, Petra ^a,b   Skoog, Lambert ^a   Höög, Anders ^a   Wallin, Göran ^b   Zadenius, Jan ^b   Larsson, Catharina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cytology; Fine needle aspiration biopsy; Ki 67; MIB 1; Prognosis; Thyroid

Indexed keywords

KI 67 ANTIGEN; ANTINUCLEAR ANTIBODY; MIB 1 ANTIBODY; MIB-1 ANTIBODY; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; ASPIRATION BIOPSY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC VALUE; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; THYROID ADENOMA; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT PLANNING; TUMOR VOLUME; IMMUNOLOGY; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; PAPILLARY CARCINOMA; PATHOLOGY; THYROID GLAND; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; BIOPSY, NEEDLE; CARCINOMA, PAPILLARY; CELL PROLIFERATION; CHILD; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROGNOSIS; THYROID GLAND; THYROID NEOPLASMS;

EID: 69449101988     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000348     Document Type: Article

References (29)

1. Dean DS and Gharib H: Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 22: 901-911, 2008.
2. Sherman SI: Thyroid carcinoma. Lancet 361: 501-511, 2003.
3. LiVolsi VA, Mazzaferri EL, Schneider AB, et al: Papillary Carcinoma. In: Classification of tumours: Pathology and genetics of tumours of endocrine organs. WHO classification of tumors. DeLellis RA, Heitz PU and Eng C (eds). IARC Press, Lyon, pp57-66, 2004.
4. Gharib H and Goellner JR: Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118: 282-289, 1993.
5. Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos AP, Orlandi F and Papotti M: Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer 12: 305-317, 2005.
6. Kjellman P, Wallin G, Hoog A, Auer G, Larsson C and Zedenius J: MIB-1 index in thyroid tumors: a predictor of the clinical course in papillary thyroid carcinoma. Thyroid 13: 371-380, 2003.
7. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J and Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363, 1992.
8. Brown DC and Gatter KC: Ki67 protein: the immaculate deception? Histopathology 40: 2-11, 2002.
9. Mar KC, Eimoto T, Nagaya S and Tateyama H: Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid. Histopathology 48: 801-807, 2006.
10. Mehrotra P, Gonzalez MA, Johnson SJ, Coleman N, Wilson JA, Davies BR and Lennard TW: Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy. Laryngoscope 116: 1434-1438, 2006.
11. Kjellman P, Zedenius J, Lundell G, Backdahl M, Farnebo LO, Hamberger B, Larsson C and Wallin G: Predictors of outcome in patients with papillary thyroid carcinoma. Eur J Surg Oncol 32: 345-352, 2006.
12. Zajicek J: Aspiration biopsy cytology. Lymphology 10: 94-101, 1977.
13. Billgren AM, Tani E, Liedberg A, Skoog L and Rutqvist LE: Prognostic significance of tumor cell proliferation analyzed in fine needle aspirates from primary breast cancer. Breast Cancer Res Treat 71: 161-170, 2002.
14. Veronese SM, Maisano C and Scibilia J: Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer. Anticancer Res 15: 2717-2722, 1995.
15. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVolsi VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA and Stockigt JR: Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13: 3-126, 2003.
16. British Thyroid Association: Royal College of Physicians: Report of the Thyroid Cancer Guidelines Update Group. In: Guidelines for the management of thyroid cancer. Perros P (ed). 2nd edition, Royal College of Physicians, London, 2007.
17. American Joint Committee on Cancer: Cancer Staging Manual. 6th edition, Springer, Chicago, 2002.
18. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U and Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984.
19. Mehrotra A, Goel MM and Singh K: Ki-67 and AgNOR proliferative markers as diagnostic adjuncts to fine needle aspiration cytology of thyroid follicular lesions. Analytical and quantitative cytology and histology/ the International Academy of Cytology (and) American Society of Cytology 24: 205-211, 2002.
20. Saltman B, Singh B, Hedvat CV, Wreesmann VB and Ghossein R: Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression. Surgery 140: 899-905; discussion 905-896, 2006.
21. Rickert D, Mittermayer C, Lindenfelser R and Biesterfeld S: MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland. Analytical and quantitative cytology and histology/the International Academy of Cytology (and) American Society of Cytology 22: 229-234, 2000.
22. Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J and Lloyd RV: Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Mod Pathol 11: 169-174, 1998.
23. Nakamura N, Erickson LA, Jin L, Kajita S, Zhang H, Qian X, Rumilla K and Lloyd RV: Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma. Endocr Pathol 17: 213-223, 2006.
24. Werga P, Wallin G, Skoog L and Hamberger B: Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management. World J Surg 24: 907-912, 2000.
25. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS and Sturgeon C: Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246: 375-381, 2007.
26. Dralle H and Machens A: Surgical approaches in thyroid cancer and lymph-node metastases. Best Pract Res Clin Endocrinol Metab 22: 971-987, 2008.
27. Lee YS, Kim SW, Kim SW, Kim SK, Kang HS, Lee ES and Chung KW: Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg 31: 1954-1959, 2007.
28. Ito Y, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K and Miyauchi A: Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination. Oncology 68: 87-96, 2005.
29. Siironen P, Louhimo J, Nordling S, Ristimaki A, Maenpaa H, Haapiainen R and Haglund C: Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients. Tumour Biol 26: 57-64, 2005.